Answers are grounded in this paper and cite their sources.
Ibipinabant may have weight loss-independent antidiabetic effects and may have the potential to attenuate β-cell loss in a model of progressive β-cell dysfunction.
No takes yet. Share an insight, caveat, or question.
Rohrbach et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: